Connect with us

Reports

COVID-19 report

Anyone thinking that 2020 might travel down a predictable path for the biopharma sector was swiftly disabused of this view in the opening weeks of the year. The coronavirus pandemic has changed the focus for almost every drug developer, whether they are working on potential treatments or trying to keep their businesses on track – or both.

Copyright © 2024 Medical Buyer

error: Content is protected !!